The BD Max GC rtPCR assay from BD Diagnostics, Baltimore, Md, has received the CE mark for sale and distribution in Europe. An in vitro diagnostic test, the assay is designed for use with specimens that have tested positive for Neisseria gonorrhoeae (GC) with the BD ProbeTec GC Qx amplified DNA assay performed on the BD Viper system. The assay may be used for detection of GC DNA in residual male or female urine specimens or residual endocervical vaginal or male urethral swab specimens. Automated DNA extraction amplification and detection maximize laboratory efficiency and quality of results, while the assay’s high specificity helps to improve the positive predictive value in low prevalence populations. Neisseria gonorrhoeae is one of the most prevalent sexually transmitted bacterial infections, with total cases estimated at more than 106 million worldwide. For more information, visit BD Diagnostics.
ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for Covid-19, Other Viruses
February 10, 2021